Compile Data Set for Download or QSAR

Found 102 hits with Last Name = 'royo' and Initial = 's'   

Target/Host (Institution)	Ligand	Target/Host Links	Ligand Links	Trg + Lig Links	Ki nM	ΔG° kJ/mole	IC50 nM	Kd nM	EC50/IC50 nM	koff s-1	kon M-1s-1	pH	Temp °C
Cathepsin B (Homo sapiens (Human))	BDBM50463145 (CHEMBL4244085) Show SMILES CCOC(=O)\C=C\C=C\C(=O)[C@H](CCc1ccccc1)NC(=O)[C@H](Cc1ccccc1)NC(=O)N1CCOCC1 |r| Show InChI InChI=1S/C31H37N3O6/c1-2-40-29(36)16-10-9-15-28(35)26(18-17-24-11-5-3-6-12-24)32-30(37)27(23-25-13-7-4-8-14-25)33-31(38)34-19-21-39-22-20-34/h3-16,26-27H,2,17-23H2,1H3,(H,32,37)(H,33,38)/b15-9+,16-10+/t26-,27-/m0/s1	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	Article PubMed	1.40E+3	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Universitat Jaume I Curated by ChEMBL					Assay Description Inhibition of human cathepsin B using Cbz-Phe-Arg-AMC as substrate				Bioorg Med Chem 26: 4624-4634 (2018) Article DOI: 10.1016/j.bmc.2018.07.015 BindingDB Entry DOI: 10.7270/Q29S1TPM
					More data for this Ligand-Target Pair
Procathepsin L (Homo sapiens (Human))	BDBM50463145 (CHEMBL4244085) Show SMILES CCOC(=O)\C=C\C=C\C(=O)[C@H](CCc1ccccc1)NC(=O)[C@H](Cc1ccccc1)NC(=O)N1CCOCC1 |r| Show InChI InChI=1S/C31H37N3O6/c1-2-40-29(36)16-10-9-15-28(35)26(18-17-24-11-5-3-6-12-24)32-30(37)27(23-25-13-7-4-8-14-25)33-31(38)34-19-21-39-22-20-34/h3-16,26-27H,2,17-23H2,1H3,(H,32,37)(H,33,38)/b15-9+,16-10+/t26-,27-/m0/s1	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	Article PubMed	7.80E+5	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Universitat Jaume I Curated by ChEMBL					Assay Description Inhibition of human cathepsin L using Cbz-Phe-Arg-AMC as substrate				Bioorg Med Chem 26: 4624-4634 (2018) Article DOI: 10.1016/j.bmc.2018.07.015 BindingDB Entry DOI: 10.7270/Q29S1TPM
					More data for this Ligand-Target Pair
Prolyl endopeptidase-like (Human)	BDBM298372 ((S)-1-((S)-1-(4-(benzyloxy)-3-(trifluoromethyl)ben...) Show SMILES FC(F)(F)c1cc(ccc1OCc1ccccc1)C(=O)N1CC(F)(F)C[C@H]1C(=O)N1CCC[C@H]1C#N |r| Show InChI InChI=1S/C25H22F5N3O3/c26-24(27)12-20(23(35)32-10-4-7-18(32)13-31)33(15-24)22(34)17-8-9-21(19(11-17)25(28,29)30)36-14-16-5-2-1-3-6-16/h1-3,5-6,8-9,11,18,20H,4,7,10,12,14-15H2/t18-,20-/m0/s1	PDB UniProtKB/SwissProt GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	4.5	n/a	n/a	n/a	n/a	n/a	n/a
UNIVERSITAT DE BARCELONA; FUNACIÓ INSTITUT DE RECERCA BIOMÉDICA; IPROTEOS S.L. US Patent					Assay Description POP activity was determined following the method described by Toide et al (Toide K et al., J. Pharmacol. Exp. Ther. 1995; 274:1370-8), using Z-G-P-AM...				US Patent US10611727 (2020) BindingDB Entry DOI: 10.7270/Q2377CQK
					More data for this Ligand-Target Pair
Prolyl endopeptidase (Homo sapiens (Human))	BDBM298372 ((S)-1-((S)-1-(4-(benzyloxy)-3-(trifluoromethyl)ben...) Show SMILES FC(F)(F)c1cc(ccc1OCc1ccccc1)C(=O)N1CC(F)(F)C[C@H]1C(=O)N1CCC[C@H]1C#N |r| Show InChI InChI=1S/C25H22F5N3O3/c26-24(27)12-20(23(35)32-10-4-7-18(32)13-31)33(15-24)22(34)17-8-9-21(19(11-17)25(28,29)30)36-14-16-5-2-1-3-6-16/h1-3,5-6,8-9,11,18,20H,4,7,10,12,14-15H2/t18-,20-/m0/s1	PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	4.5	n/a	n/a	n/a	n/a	n/a	n/a
UNIVERSITAT DE BARCELONA; FUNDACIO INSTITUT DE RECERCA BIOMEDICA (IRB BARCELONA); IPROTEOS S.L. US Patent					Assay Description POP activity was determined following the method described by Toide et al (Toide K et al., J. Pharmacol. Exp. Ther. 1995; 274:1370-8), using Z-G-P-AM...				US Patent US10125097 (2018) BindingDB Entry DOI: 10.7270/Q22J6DX3
					More data for this Ligand-Target Pair
Prolyl endopeptidase (Homo sapiens (Human))	BDBM298373 ((S)-1-((S)-1-(4-(benzyloxy)-3-fluorobenzoyl)-4,4-d...) Show SMILES Fc1cc(ccc1OCc1ccccc1)C(=O)N1CC(F)(F)C[C@H]1C(=O)N1CCC[C@H]1C#N |r| Show InChI InChI=1S/C24H22F3N3O3/c25-19-11-17(8-9-21(19)33-14-16-5-2-1-3-6-16)22(31)30-15-24(26,27)12-20(30)23(32)29-10-4-7-18(29)13-28/h1-3,5-6,8-9,11,18,20H,4,7,10,12,14-15H2/t18-,20-/m0/s1	PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	5	n/a	n/a	n/a	n/a	n/a	n/a
UNIVERSITAT DE BARCELONA; FUNDACIO INSTITUT DE RECERCA BIOMEDICA (IRB BARCELONA); IPROTEOS S.L. US Patent					Assay Description POP activity was determined following the method described by Toide et al (Toide K et al., J. Pharmacol. Exp. Ther. 1995; 274:1370-8), using Z-G-P-AM...				US Patent US10125097 (2018) BindingDB Entry DOI: 10.7270/Q22J6DX3
					More data for this Ligand-Target Pair
Prolyl endopeptidase-like (Human)	BDBM298373 ((S)-1-((S)-1-(4-(benzyloxy)-3-fluorobenzoyl)-4,4-d...) Show SMILES Fc1cc(ccc1OCc1ccccc1)C(=O)N1CC(F)(F)C[C@H]1C(=O)N1CCC[C@H]1C#N |r| Show InChI InChI=1S/C24H22F3N3O3/c25-19-11-17(8-9-21(19)33-14-16-5-2-1-3-6-16)22(31)30-15-24(26,27)12-20(30)23(32)29-10-4-7-18(29)13-28/h1-3,5-6,8-9,11,18,20H,4,7,10,12,14-15H2/t18-,20-/m0/s1	PDB UniProtKB/SwissProt GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	5	n/a	n/a	n/a	n/a	n/a	n/a
UNIVERSITAT DE BARCELONA; FUNACIÓ INSTITUT DE RECERCA BIOMÉDICA; IPROTEOS S.L. US Patent					Assay Description POP activity was determined following the method described by Toide et al (Toide K et al., J. Pharmacol. Exp. Ther. 1995; 274:1370-8), using Z-G-P-AM...				US Patent US10611727 (2020) BindingDB Entry DOI: 10.7270/Q2377CQK
					More data for this Ligand-Target Pair
Procathepsin L (Homo sapiens (Human))	BDBM50463157 (CHEMBL4244656) Show SMILES CCOC(=O)\C=C\C(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)OCc1ccccc1 |r| Show InChI InChI=1S/C28H34N2O6/c1-4-35-26(32)16-15-25(31)23(17-20(2)3)29-27(33)24(18-21-11-7-5-8-12-21)30-28(34)36-19-22-13-9-6-10-14-22/h5-16,20,23-24H,4,17-19H2,1-3H3,(H,29,33)(H,30,34)/b16-15+/t23-,24-/m0/s1	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	Article PubMed	n/a	n/a	10	n/a	n/a	n/a	n/a	n/a	n/a
Universitat Jaume I Curated by ChEMBL					Assay Description Inhibition of human cathepsin L using Cbz-Phe-Arg-AMC as substrate				Bioorg Med Chem 26: 4624-4634 (2018) Article DOI: 10.1016/j.bmc.2018.07.015 BindingDB Entry DOI: 10.7270/Q29S1TPM
					More data for this Ligand-Target Pair
Procathepsin L (Homo sapiens (Human))	BDBM50463142 (CHEMBL4238441) Show SMILES CCOC(=O)\C=C\C(=O)[C@@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)OCc1ccccc1 |r| Show InChI InChI=1S/C28H34N2O6/c1-4-35-26(32)16-15-25(31)23(17-20(2)3)29-27(33)24(18-21-11-7-5-8-12-21)30-28(34)36-19-22-13-9-6-10-14-22/h5-16,20,23-24H,4,17-19H2,1-3H3,(H,29,33)(H,30,34)/b16-15+/t23-,24+/m1/s1	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	Article PubMed	n/a	n/a	10	n/a	n/a	n/a	n/a	n/a	n/a
Universitat Jaume I Curated by ChEMBL					Assay Description Inhibition of human cathepsin L using Cbz-Phe-Arg-AMC as substrate				Bioorg Med Chem 26: 4624-4634 (2018) Article DOI: 10.1016/j.bmc.2018.07.015 BindingDB Entry DOI: 10.7270/Q29S1TPM
					More data for this Ligand-Target Pair
Prolyl endopeptidase-like (Human)	BDBM298357 ((S)-1-((2S,4S)-1-(4-(benzyloxy)-3,5-dimethoxybenzo...) Show SMILES COc1cc(cc(OC)c1OCc1ccccc1)C(=O)N1C[C@@H](C)C[C@H]1C(=O)N1CCC[C@H]1C#N |r| Show InChI InChI=1S/C27H31N3O5/c1-18-12-22(27(32)29-11-7-10-21(29)15-28)30(16-18)26(31)20-13-23(33-2)25(24(14-20)34-3)35-17-19-8-5-4-6-9-19/h4-6,8-9,13-14,18,21-22H,7,10-12,16-17H2,1-3H3/t18-,21-,22-/m0/s1	PDB UniProtKB/SwissProt GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	13.1	n/a	n/a	n/a	n/a	n/a	n/a
UNIVERSITAT DE BARCELONA; FUNACIÓ INSTITUT DE RECERCA BIOMÉDICA; IPROTEOS S.L. US Patent					Assay Description POP activity was determined following the method described by Toide et al (Toide K et al., J. Pharmacol. Exp. Ther. 1995; 274:1370-8), using Z-G-P-AM...				US Patent US10611727 (2020) BindingDB Entry DOI: 10.7270/Q2377CQK
					More data for this Ligand-Target Pair
Prolyl endopeptidase (Homo sapiens (Human))	BDBM298357 ((S)-1-((2S,4S)-1-(4-(benzyloxy)-3,5-dimethoxybenzo...) Show SMILES COc1cc(cc(OC)c1OCc1ccccc1)C(=O)N1C[C@@H](C)C[C@H]1C(=O)N1CCC[C@H]1C#N |r| Show InChI InChI=1S/C27H31N3O5/c1-18-12-22(27(32)29-11-7-10-21(29)15-28)30(16-18)26(31)20-13-23(33-2)25(24(14-20)34-3)35-17-19-8-5-4-6-9-19/h4-6,8-9,13-14,18,21-22H,7,10-12,16-17H2,1-3H3/t18-,21-,22-/m0/s1	PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	13.1	n/a	n/a	n/a	n/a	n/a	n/a
UNIVERSITAT DE BARCELONA; FUNDACIO INSTITUT DE RECERCA BIOMEDICA (IRB BARCELONA); IPROTEOS S.L. US Patent					Assay Description POP activity was determined following the method described by Toide et al (Toide K et al., J. Pharmacol. Exp. Ther. 1995; 274:1370-8), using Z-G-P-AM...				US Patent US10125097 (2018) BindingDB Entry DOI: 10.7270/Q22J6DX3
					More data for this Ligand-Target Pair
Cruzipain (Trypanosoma cruzi)	BDBM50463157 (CHEMBL4244656) Show SMILES CCOC(=O)\C=C\C(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)OCc1ccccc1 |r| Show InChI InChI=1S/C28H34N2O6/c1-4-35-26(32)16-15-25(31)23(17-20(2)3)29-27(33)24(18-21-11-7-5-8-12-21)30-28(34)36-19-22-13-9-6-10-14-22/h5-16,20,23-24H,4,17-19H2,1-3H3,(H,29,33)(H,30,34)/b16-15+/t23-,24-/m0/s1	PDB MMDB UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet	PC cid PC sid UniChem	Article PubMed	n/a	n/a	20	n/a	n/a	n/a	n/a	n/a	n/a
Universitat Jaume I Curated by ChEMBL					Assay Description Inhibition of Trypanosoma cruzi cruzain				Bioorg Med Chem 26: 4624-4634 (2018) Article DOI: 10.1016/j.bmc.2018.07.015 BindingDB Entry DOI: 10.7270/Q29S1TPM
					More data for this Ligand-Target Pair
Cruzipain (Trypanosoma cruzi)	BDBM50463142 (CHEMBL4238441) Show SMILES CCOC(=O)\C=C\C(=O)[C@@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)OCc1ccccc1 |r| Show InChI InChI=1S/C28H34N2O6/c1-4-35-26(32)16-15-25(31)23(17-20(2)3)29-27(33)24(18-21-11-7-5-8-12-21)30-28(34)36-19-22-13-9-6-10-14-22/h5-16,20,23-24H,4,17-19H2,1-3H3,(H,29,33)(H,30,34)/b16-15+/t23-,24+/m1/s1	PDB MMDB UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet	PC cid PC sid UniChem	Article PubMed	n/a	n/a	20	n/a	n/a	n/a	n/a	n/a	n/a
Universitat Jaume I Curated by ChEMBL					Assay Description Inhibition of Trypanosoma cruzi cruzain				Bioorg Med Chem 26: 4624-4634 (2018) Article DOI: 10.1016/j.bmc.2018.07.015 BindingDB Entry DOI: 10.7270/Q29S1TPM
					More data for this Ligand-Target Pair
Cysteine protease (Trypanosoma brucei rhodesiense)	BDBM50463157 (CHEMBL4244656) Show SMILES CCOC(=O)\C=C\C(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)OCc1ccccc1 |r| Show InChI InChI=1S/C28H34N2O6/c1-4-35-26(32)16-15-25(31)23(17-20(2)3)29-27(33)24(18-21-11-7-5-8-12-21)30-28(34)36-19-22-13-9-6-10-14-22/h5-16,20,23-24H,4,17-19H2,1-3H3,(H,29,33)(H,30,34)/b16-15+/t23-,24-/m0/s1	PDB MMDB UniProtKB/TrEMBL B.MOAD GoogleScholar AffyNet	PC cid PC sid UniChem	Article PubMed	n/a	n/a	20	n/a	n/a	n/a	n/a	n/a	n/a
Universitat Jaume I Curated by ChEMBL					Assay Description Inhibition of Trypanosoma brucei rhodesiense rhodesain using Cbz-Phe-Arg-AMC as substrate measured for 30 mins by fluorescence method				Bioorg Med Chem 26: 4624-4634 (2018) Article DOI: 10.1016/j.bmc.2018.07.015 BindingDB Entry DOI: 10.7270/Q29S1TPM
					More data for this Ligand-Target Pair
Cysteine protease (Trypanosoma brucei rhodesiense)	BDBM50463154 (CHEMBL4251480) Show SMILES CCOC(=O)\C=C\C(=O)[C@H](CCc1ccccc1)NC(=O)[C@H](Cc1ccccc1)NC(=O)OCc1ccccc1 |r| Show InChI InChI=1S/C32H34N2O6/c1-2-39-30(36)21-20-29(35)27(19-18-24-12-6-3-7-13-24)33-31(37)28(22-25-14-8-4-9-15-25)34-32(38)40-23-26-16-10-5-11-17-26/h3-17,20-21,27-28H,2,18-19,22-23H2,1H3,(H,33,37)(H,34,38)/b21-20+/t27-,28-/m0/s1	PDB MMDB UniProtKB/TrEMBL B.MOAD GoogleScholar AffyNet	PC cid PC sid UniChem	Article PubMed	n/a	n/a	30	n/a	n/a	n/a	n/a	n/a	n/a
Universitat Jaume I Curated by ChEMBL					Assay Description Inhibition of Trypanosoma brucei rhodesiense rhodesain using Cbz-Phe-Arg-AMC as substrate measured for 30 mins by fluorescence method				Bioorg Med Chem 26: 4624-4634 (2018) Article DOI: 10.1016/j.bmc.2018.07.015 BindingDB Entry DOI: 10.7270/Q29S1TPM
					More data for this Ligand-Target Pair
Cysteine protease (Trypanosoma brucei rhodesiense)	BDBM50463142 (CHEMBL4238441) Show SMILES CCOC(=O)\C=C\C(=O)[C@@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)OCc1ccccc1 |r| Show InChI InChI=1S/C28H34N2O6/c1-4-35-26(32)16-15-25(31)23(17-20(2)3)29-27(33)24(18-21-11-7-5-8-12-21)30-28(34)36-19-22-13-9-6-10-14-22/h5-16,20,23-24H,4,17-19H2,1-3H3,(H,29,33)(H,30,34)/b16-15+/t23-,24+/m1/s1	PDB MMDB UniProtKB/TrEMBL B.MOAD GoogleScholar AffyNet	PC cid PC sid UniChem	Article PubMed	n/a	n/a	30	n/a	n/a	n/a	n/a	n/a	n/a
Universitat Jaume I Curated by ChEMBL					Assay Description Inhibition of Trypanosoma brucei rhodesiense rhodesain using Cbz-Phe-Arg-AMC as substrate measured for 30 mins by fluorescence method				Bioorg Med Chem 26: 4624-4634 (2018) Article DOI: 10.1016/j.bmc.2018.07.015 BindingDB Entry DOI: 10.7270/Q29S1TPM
					More data for this Ligand-Target Pair
Prolyl endopeptidase-like (Human)	BDBM298355 ((S)-1-((2S)-1-(4-(benzyloxy)-3,5-dimethoxybenzoyl)...) Show SMILES COc1cc(cc(OC)c1OCc1ccccc1)C(=O)N1CC(F)(F)C[C@H]1C(=O)N1CCC[C@H]1C#N |r| Show InChI InChI=1S/C26H27F2N3O5/c1-34-21-11-18(12-22(35-2)23(21)36-15-17-7-4-3-5-8-17)24(32)31-16-26(27,28)13-20(31)25(33)30-10-6-9-19(30)14-29/h3-5,7-8,11-12,19-20H,6,9-10,13,15-16H2,1-2H3/t19-,20-/m0/s1	PDB UniProtKB/SwissProt GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	48.7	n/a	n/a	n/a	n/a	n/a	n/a
UNIVERSITAT DE BARCELONA; FUNACIÓ INSTITUT DE RECERCA BIOMÉDICA; IPROTEOS S.L. US Patent					Assay Description POP activity was determined following the method described by Toide et al (Toide K et al., J. Pharmacol. Exp. Ther. 1995; 274:1370-8), using Z-G-P-AM...				US Patent US10611727 (2020) BindingDB Entry DOI: 10.7270/Q2377CQK
					More data for this Ligand-Target Pair
Prolyl endopeptidase (Homo sapiens (Human))	BDBM298355 ((S)-1-((2S)-1-(4-(benzyloxy)-3,5-dimethoxybenzoyl)...) Show SMILES COc1cc(cc(OC)c1OCc1ccccc1)C(=O)N1CC(F)(F)C[C@H]1C(=O)N1CCC[C@H]1C#N |r| Show InChI InChI=1S/C26H27F2N3O5/c1-34-21-11-18(12-22(35-2)23(21)36-15-17-7-4-3-5-8-17)24(32)31-16-26(27,28)13-20(31)25(33)30-10-6-9-19(30)14-29/h3-5,7-8,11-12,19-20H,6,9-10,13,15-16H2,1-2H3/t19-,20-/m0/s1	PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	48.7	n/a	n/a	n/a	n/a	n/a	n/a
UNIVERSITAT DE BARCELONA; FUNDACIO INSTITUT DE RECERCA BIOMEDICA (IRB BARCELONA); IPROTEOS S.L. US Patent					Assay Description POP activity was determined following the method described by Toide et al (Toide K et al., J. Pharmacol. Exp. Ther. 1995; 274:1370-8), using Z-G-P-AM...				US Patent US10125097 (2018) BindingDB Entry DOI: 10.7270/Q22J6DX3
					More data for this Ligand-Target Pair
Cathepsin B (Homo sapiens (Human))	BDBM50463143 (CHEMBL4245127) Show SMILES CCOC(=O)\C=C\C(=O)[C@H](CCc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)OCc1ccccc1 |r| Show InChI InChI=1S/C29H36N2O6/c1-4-36-27(33)18-17-26(32)24(16-15-22-11-7-5-8-12-22)30-28(34)25(19-21(2)3)31-29(35)37-20-23-13-9-6-10-14-23/h5-14,17-18,21,24-25H,4,15-16,19-20H2,1-3H3,(H,30,34)(H,31,35)/b18-17+/t24-,25-/m0/s1	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	Article PubMed	n/a	n/a	50	n/a	n/a	n/a	n/a	n/a	n/a
Universitat Jaume I Curated by ChEMBL					Assay Description Inhibition of human cathepsin B using Cbz-Phe-Arg-AMC as substrate				Bioorg Med Chem 26: 4624-4634 (2018) Article DOI: 10.1016/j.bmc.2018.07.015 BindingDB Entry DOI: 10.7270/Q29S1TPM
					More data for this Ligand-Target Pair
Cathepsin B (Homo sapiens (Human))	BDBM50463157 (CHEMBL4244656) Show SMILES CCOC(=O)\C=C\C(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)OCc1ccccc1 |r| Show InChI InChI=1S/C28H34N2O6/c1-4-35-26(32)16-15-25(31)23(17-20(2)3)29-27(33)24(18-21-11-7-5-8-12-21)30-28(34)36-19-22-13-9-6-10-14-22/h5-16,20,23-24H,4,17-19H2,1-3H3,(H,29,33)(H,30,34)/b16-15+/t23-,24-/m0/s1	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	Article PubMed	n/a	n/a	50	n/a	n/a	n/a	n/a	n/a	n/a
Universitat Jaume I Curated by ChEMBL					Assay Description Inhibition of human cathepsin B using Cbz-Phe-Arg-AMC as substrate				Bioorg Med Chem 26: 4624-4634 (2018) Article DOI: 10.1016/j.bmc.2018.07.015 BindingDB Entry DOI: 10.7270/Q29S1TPM
					More data for this Ligand-Target Pair
Procathepsin L (Homo sapiens (Human))	BDBM50463154 (CHEMBL4251480) Show SMILES CCOC(=O)\C=C\C(=O)[C@H](CCc1ccccc1)NC(=O)[C@H](Cc1ccccc1)NC(=O)OCc1ccccc1 |r| Show InChI InChI=1S/C32H34N2O6/c1-2-39-30(36)21-20-29(35)27(19-18-24-12-6-3-7-13-24)33-31(37)28(22-25-14-8-4-9-15-25)34-32(38)40-23-26-16-10-5-11-17-26/h3-17,20-21,27-28H,2,18-19,22-23H2,1H3,(H,33,37)(H,34,38)/b21-20+/t27-,28-/m0/s1	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	Article PubMed	n/a	n/a	50	n/a	n/a	n/a	n/a	n/a	n/a
Universitat Jaume I Curated by ChEMBL					Assay Description Inhibition of human cathepsin L using Cbz-Phe-Arg-AMC as substrate				Bioorg Med Chem 26: 4624-4634 (2018) Article DOI: 10.1016/j.bmc.2018.07.015 BindingDB Entry DOI: 10.7270/Q29S1TPM
					More data for this Ligand-Target Pair
Cathepsin B (Homo sapiens (Human))	BDBM50463142 (CHEMBL4238441) Show SMILES CCOC(=O)\C=C\C(=O)[C@@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)OCc1ccccc1 |r| Show InChI InChI=1S/C28H34N2O6/c1-4-35-26(32)16-15-25(31)23(17-20(2)3)29-27(33)24(18-21-11-7-5-8-12-21)30-28(34)36-19-22-13-9-6-10-14-22/h5-16,20,23-24H,4,17-19H2,1-3H3,(H,29,33)(H,30,34)/b16-15+/t23-,24+/m1/s1	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	Article PubMed	n/a	n/a	60	n/a	n/a	n/a	n/a	n/a	n/a
Universitat Jaume I Curated by ChEMBL					Assay Description Inhibition of human cathepsin B using Cbz-Phe-Arg-AMC as substrate				Bioorg Med Chem 26: 4624-4634 (2018) Article DOI: 10.1016/j.bmc.2018.07.015 BindingDB Entry DOI: 10.7270/Q29S1TPM
					More data for this Ligand-Target Pair
Cysteine proteinase falcipain 2a (Plasmodium falciparum)	BDBM50463154 (CHEMBL4251480) Show SMILES CCOC(=O)\C=C\C(=O)[C@H](CCc1ccccc1)NC(=O)[C@H](Cc1ccccc1)NC(=O)OCc1ccccc1 |r| Show InChI InChI=1S/C32H34N2O6/c1-2-39-30(36)21-20-29(35)27(19-18-24-12-6-3-7-13-24)33-31(37)28(22-25-14-8-4-9-15-25)34-32(38)40-23-26-16-10-5-11-17-26/h3-17,20-21,27-28H,2,18-19,22-23H2,1H3,(H,33,37)(H,34,38)/b21-20+/t27-,28-/m0/s1	PDB MMDB UniProtKB/TrEMBL B.MOAD GoogleScholar AffyNet	PC cid PC sid UniChem	Article PubMed	n/a	n/a	60	n/a	n/a	n/a	n/a	n/a	n/a
Universitat Jaume I Curated by ChEMBL					Assay Description Inhibition of Plasmodium falciparum falcipain-2 using Cbz-Phe-Arg-AMC as substrate measured for 15 mins by spectrofluorimetric method				Bioorg Med Chem 26: 4624-4634 (2018) Article DOI: 10.1016/j.bmc.2018.07.015 BindingDB Entry DOI: 10.7270/Q29S1TPM
					More data for this Ligand-Target Pair
Prolyl endopeptidase (Homo sapiens (Human))	BDBM298352 ((S)-1-((2S,4R)-1-(4-(benzyloxy)-3,5-dimethoxybenzo...) Show SMILES COc1cc(cc(OC)c1OCc1ccccc1)C(=O)N1C[C@H](F)C[C@H]1C(=O)N1CCC[C@H]1C#N |r| Show InChI InChI=1S/C26H28FN3O5/c1-33-22-11-18(12-23(34-2)24(22)35-16-17-7-4-3-5-8-17)25(31)30-15-19(27)13-21(30)26(32)29-10-6-9-20(29)14-28/h3-5,7-8,11-12,19-21H,6,9-10,13,15-16H2,1-2H3/t19-,20+,21+/m1/s1	PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	60.4	n/a	n/a	n/a	n/a	n/a	n/a
UNIVERSITAT DE BARCELONA; FUNDACIO INSTITUT DE RECERCA BIOMEDICA (IRB BARCELONA); IPROTEOS S.L. US Patent					Assay Description POP activity was determined following the method described by Toide et al (Toide K et al., J. Pharmacol. Exp. Ther. 1995; 274:1370-8), using Z-G-P-AM...				US Patent US10125097 (2018) BindingDB Entry DOI: 10.7270/Q22J6DX3
					More data for this Ligand-Target Pair
Prolyl endopeptidase-like (Human)	BDBM298352 ((S)-1-((2S,4R)-1-(4-(benzyloxy)-3,5-dimethoxybenzo...) Show SMILES COc1cc(cc(OC)c1OCc1ccccc1)C(=O)N1C[C@H](F)C[C@H]1C(=O)N1CCC[C@H]1C#N |r| Show InChI InChI=1S/C26H28FN3O5/c1-33-22-11-18(12-23(34-2)24(22)35-16-17-7-4-3-5-8-17)25(31)30-15-19(27)13-21(30)26(32)29-10-6-9-20(29)14-28/h3-5,7-8,11-12,19-21H,6,9-10,13,15-16H2,1-2H3/t19-,20+,21+/m1/s1	PDB UniProtKB/SwissProt GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	60.4	n/a	n/a	n/a	n/a	n/a	n/a
UNIVERSITAT DE BARCELONA; FUNACIÓ INSTITUT DE RECERCA BIOMÉDICA; IPROTEOS S.L. US Patent					Assay Description POP activity was determined following the method described by Toide et al (Toide K et al., J. Pharmacol. Exp. Ther. 1995; 274:1370-8), using Z-G-P-AM...				US Patent US10611727 (2020) BindingDB Entry DOI: 10.7270/Q2377CQK
					More data for this Ligand-Target Pair
Prolyl endopeptidase (Homo sapiens (Human))	BDBM298345 ((S)-1-((2S,4R)-1-(4-(benzyloxy)-3,5-dimethoxybenzo...) Show SMILES CO[C@@H]1C[C@H](N(C1)C(=O)c1cc(OC)c(OCc2ccccc2)c(OC)c1)C(=O)N1CCC[C@H]1C#N |r| Show InChI InChI=1S/C27H31N3O6/c1-33-21-14-22(27(32)29-11-7-10-20(29)15-28)30(16-21)26(31)19-12-23(34-2)25(24(13-19)35-3)36-17-18-8-5-4-6-9-18/h4-6,8-9,12-13,20-22H,7,10-11,14,16-17H2,1-3H3/t20-,21+,22-/m0/s1	PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	63.8	n/a	n/a	n/a	n/a	n/a	n/a
UNIVERSITAT DE BARCELONA; FUNDACIO INSTITUT DE RECERCA BIOMEDICA (IRB BARCELONA); IPROTEOS S.L. US Patent					Assay Description POP activity was determined following the method described by Toide et al (Toide K et al., J. Pharmacol. Exp. Ther. 1995; 274:1370-8), using Z-G-P-AM...				US Patent US10125097 (2018) BindingDB Entry DOI: 10.7270/Q22J6DX3
					More data for this Ligand-Target Pair
Prolyl endopeptidase-like (Human)	BDBM298345 ((S)-1-((2S,4R)-1-(4-(benzyloxy)-3,5-dimethoxybenzo...) Show SMILES CO[C@@H]1C[C@H](N(C1)C(=O)c1cc(OC)c(OCc2ccccc2)c(OC)c1)C(=O)N1CCC[C@H]1C#N |r| Show InChI InChI=1S/C27H31N3O6/c1-33-21-14-22(27(32)29-11-7-10-20(29)15-28)30(16-21)26(31)19-12-23(34-2)25(24(13-19)35-3)36-17-18-8-5-4-6-9-18/h4-6,8-9,12-13,20-22H,7,10-11,14,16-17H2,1-3H3/t20-,21+,22-/m0/s1	PDB UniProtKB/SwissProt GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	63.8	n/a	n/a	n/a	n/a	n/a	n/a
UNIVERSITAT DE BARCELONA; FUNACIÓ INSTITUT DE RECERCA BIOMÉDICA; IPROTEOS S.L. US Patent					Assay Description POP activity was determined following the method described by Toide et al (Toide K et al., J. Pharmacol. Exp. Ther. 1995; 274:1370-8), using Z-G-P-AM...				US Patent US10611727 (2020) BindingDB Entry DOI: 10.7270/Q2377CQK
					More data for this Ligand-Target Pair
Cathepsin B (Homo sapiens (Human))	BDBM50463154 (CHEMBL4251480) Show SMILES CCOC(=O)\C=C\C(=O)[C@H](CCc1ccccc1)NC(=O)[C@H](Cc1ccccc1)NC(=O)OCc1ccccc1 |r| Show InChI InChI=1S/C32H34N2O6/c1-2-39-30(36)21-20-29(35)27(19-18-24-12-6-3-7-13-24)33-31(37)28(22-25-14-8-4-9-15-25)34-32(38)40-23-26-16-10-5-11-17-26/h3-17,20-21,27-28H,2,18-19,22-23H2,1H3,(H,33,37)(H,34,38)/b21-20+/t27-,28-/m0/s1	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	Article PubMed	n/a	n/a	70	n/a	n/a	n/a	n/a	n/a	n/a
Universitat Jaume I Curated by ChEMBL					Assay Description Inhibition of human cathepsin B using Cbz-Phe-Arg-AMC as substrate				Bioorg Med Chem 26: 4624-4634 (2018) Article DOI: 10.1016/j.bmc.2018.07.015 BindingDB Entry DOI: 10.7270/Q29S1TPM
					More data for this Ligand-Target Pair
Cathepsin B (Homo sapiens (Human))	BDBM50463149 (CHEMBL4248915) Show SMILES CCOC(=O)\C=C\C(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)OCc1ccccc1 |r| Show InChI InChI=1S/C22H30N2O6/c1-5-29-20(26)12-11-19(25)16(4)23-21(27)18(13-15(2)3)24-22(28)30-14-17-9-7-6-8-10-17/h6-12,15-16,18H,5,13-14H2,1-4H3,(H,23,27)(H,24,28)/b12-11+/t16-,18-/m0/s1	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	Article PubMed	n/a	n/a	70	n/a	n/a	n/a	n/a	n/a	n/a
Universitat Jaume I Curated by ChEMBL					Assay Description Inhibition of human cathepsin B using Cbz-Phe-Arg-AMC as substrate				Bioorg Med Chem 26: 4624-4634 (2018) Article DOI: 10.1016/j.bmc.2018.07.015 BindingDB Entry DOI: 10.7270/Q29S1TPM
					More data for this Ligand-Target Pair
Cathepsin B (Homo sapiens (Human))	BDBM50463152 (CHEMBL4242138) Show SMILES CCOC(=O)\C=C\C(=O)[C@H](CCc1ccccc1)NC(=O)[C@H](Cc1ccccc1)NC(=O)N1CCOCC1 |r| Show InChI InChI=1S/C29H35N3O6/c1-2-38-27(34)16-15-26(33)24(14-13-22-9-5-3-6-10-22)30-28(35)25(21-23-11-7-4-8-12-23)31-29(36)32-17-19-37-20-18-32/h3-12,15-16,24-25H,2,13-14,17-21H2,1H3,(H,30,35)(H,31,36)/b16-15+/t24-,25-/m0/s1	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	Article PubMed	n/a	n/a	70	n/a	n/a	n/a	n/a	n/a	n/a
Universitat Jaume I Curated by ChEMBL					Assay Description Inhibition of human cathepsin B using Cbz-Phe-Arg-AMC as substrate				Bioorg Med Chem 26: 4624-4634 (2018) Article DOI: 10.1016/j.bmc.2018.07.015 BindingDB Entry DOI: 10.7270/Q29S1TPM
					More data for this Ligand-Target Pair
Cathepsin B (Homo sapiens (Human))	BDBM50463148 (CHEMBL4247707) Show SMILES CCOC(=O)\C=C\C(=O)[C@@H](CCc1ccccc1)NC(=O)[C@H](Cc1ccccc1)NC(=O)N1CCOCC1 |r| Show InChI InChI=1S/C29H35N3O6/c1-2-38-27(34)16-15-26(33)24(14-13-22-9-5-3-6-10-22)30-28(35)25(21-23-11-7-4-8-12-23)31-29(36)32-17-19-37-20-18-32/h3-12,15-16,24-25H,2,13-14,17-21H2,1H3,(H,30,35)(H,31,36)/b16-15+/t24-,25+/m1/s1	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	Article PubMed	n/a	n/a	80	n/a	n/a	n/a	n/a	n/a	n/a
Universitat Jaume I Curated by ChEMBL					Assay Description Inhibition of human cathepsin B using Cbz-Phe-Arg-AMC as substrate				Bioorg Med Chem 26: 4624-4634 (2018) Article DOI: 10.1016/j.bmc.2018.07.015 BindingDB Entry DOI: 10.7270/Q29S1TPM
					More data for this Ligand-Target Pair
Cruzipain (Trypanosoma cruzi)	BDBM50463143 (CHEMBL4245127) Show SMILES CCOC(=O)\C=C\C(=O)[C@H](CCc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)OCc1ccccc1 |r| Show InChI InChI=1S/C29H36N2O6/c1-4-36-27(33)18-17-26(32)24(16-15-22-11-7-5-8-12-22)30-28(34)25(19-21(2)3)31-29(35)37-20-23-13-9-6-10-14-23/h5-14,17-18,21,24-25H,4,15-16,19-20H2,1-3H3,(H,30,34)(H,31,35)/b18-17+/t24-,25-/m0/s1	PDB MMDB UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet	PC cid PC sid UniChem	Article PubMed	n/a	n/a	80	n/a	n/a	n/a	n/a	n/a	n/a
Universitat Jaume I Curated by ChEMBL					Assay Description Inhibition of Trypanosoma cruzi cruzain				Bioorg Med Chem 26: 4624-4634 (2018) Article DOI: 10.1016/j.bmc.2018.07.015 BindingDB Entry DOI: 10.7270/Q29S1TPM
					More data for this Ligand-Target Pair
Procathepsin L (Homo sapiens (Human))	BDBM50463146 (CHEMBL4240920) Show SMILES CCOC(=O)\C=C\C(=O)[C@H](C)NC(=O)[C@H](Cc1ccccc1)NC(=O)OCc1ccccc1 |r| Show InChI InChI=1S/C25H28N2O6/c1-3-32-23(29)15-14-22(28)18(2)26-24(30)21(16-19-10-6-4-7-11-19)27-25(31)33-17-20-12-8-5-9-13-20/h4-15,18,21H,3,16-17H2,1-2H3,(H,26,30)(H,27,31)/b15-14+/t18-,21-/m0/s1	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	Article PubMed	n/a	n/a	80	n/a	n/a	n/a	n/a	n/a	n/a
Universitat Jaume I Curated by ChEMBL					Assay Description Inhibition of human cathepsin L using Cbz-Phe-Arg-AMC as substrate				Bioorg Med Chem 26: 4624-4634 (2018) Article DOI: 10.1016/j.bmc.2018.07.015 BindingDB Entry DOI: 10.7270/Q29S1TPM
					More data for this Ligand-Target Pair
Procathepsin L (Homo sapiens (Human))	BDBM50463147 (CHEMBL4237990) Show SMILES CCOC(=O)\C=C\C(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)N1CCOCC1 |r| Show InChI InChI=1S/C22H37N3O6/c1-6-31-20(27)8-7-19(26)17(13-15(2)3)23-21(28)18(14-16(4)5)24-22(29)25-9-11-30-12-10-25/h7-8,15-18H,6,9-14H2,1-5H3,(H,23,28)(H,24,29)/b8-7+/t17-,18-/m0/s1	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	Article PubMed	n/a	n/a	90	n/a	n/a	n/a	n/a	n/a	n/a
Universitat Jaume I Curated by ChEMBL					Assay Description Inhibition of human cathepsin L using Cbz-Phe-Arg-AMC as substrate				Bioorg Med Chem 26: 4624-4634 (2018) Article DOI: 10.1016/j.bmc.2018.07.015 BindingDB Entry DOI: 10.7270/Q29S1TPM
					More data for this Ligand-Target Pair
Cathepsin B (Homo sapiens (Human))	BDBM50463147 (CHEMBL4237990) Show SMILES CCOC(=O)\C=C\C(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)N1CCOCC1 |r| Show InChI InChI=1S/C22H37N3O6/c1-6-31-20(27)8-7-19(26)17(13-15(2)3)23-21(28)18(14-16(4)5)24-22(29)25-9-11-30-12-10-25/h7-8,15-18H,6,9-14H2,1-5H3,(H,23,28)(H,24,29)/b8-7+/t17-,18-/m0/s1	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	Article PubMed	n/a	n/a	90	n/a	n/a	n/a	n/a	n/a	n/a
Universitat Jaume I Curated by ChEMBL					Assay Description Inhibition of human cathepsin B using Cbz-Phe-Arg-AMC as substrate				Bioorg Med Chem 26: 4624-4634 (2018) Article DOI: 10.1016/j.bmc.2018.07.015 BindingDB Entry DOI: 10.7270/Q29S1TPM
					More data for this Ligand-Target Pair
Cysteine protease (Trypanosoma brucei rhodesiense)	BDBM50463147 (CHEMBL4237990) Show SMILES CCOC(=O)\C=C\C(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)N1CCOCC1 |r| Show InChI InChI=1S/C22H37N3O6/c1-6-31-20(27)8-7-19(26)17(13-15(2)3)23-21(28)18(14-16(4)5)24-22(29)25-9-11-30-12-10-25/h7-8,15-18H,6,9-14H2,1-5H3,(H,23,28)(H,24,29)/b8-7+/t17-,18-/m0/s1	PDB MMDB UniProtKB/TrEMBL B.MOAD GoogleScholar AffyNet	PC cid PC sid UniChem	Article PubMed	n/a	n/a	110	n/a	n/a	n/a	n/a	n/a	n/a
Universitat Jaume I Curated by ChEMBL					Assay Description Inhibition of Trypanosoma brucei rhodesiense rhodesain using Cbz-Phe-Arg-AMC as substrate measured for 30 mins by fluorescence method				Bioorg Med Chem 26: 4624-4634 (2018) Article DOI: 10.1016/j.bmc.2018.07.015 BindingDB Entry DOI: 10.7270/Q29S1TPM
					More data for this Ligand-Target Pair
Prolyl endopeptidase-like (Human)	BDBM298363 ((S)-1-((2S)-1-(4-benzoyloxy-3,5-dimethoxybenzoyl)-...) Show SMILES COc1cc(cc(OC)c1OC(=O)c1ccccc1)C(=O)N1CC(F)(F)C[C@H]1C(=O)N1CCC[C@H]1C#N |r| Show InChI InChI=1S/C26H25F2N3O6/c1-35-20-11-17(12-21(36-2)22(20)37-25(34)16-7-4-3-5-8-16)23(32)31-15-26(27,28)13-19(31)24(33)30-10-6-9-18(30)14-29/h3-5,7-8,11-12,18-19H,6,9-10,13,15H2,1-2H3/t18-,19-/m0/s1	PDB UniProtKB/SwissProt GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	111	n/a	n/a	n/a	n/a	n/a	n/a
UNIVERSITAT DE BARCELONA; FUNACIÓ INSTITUT DE RECERCA BIOMÉDICA; IPROTEOS S.L. US Patent					Assay Description POP activity was determined following the method described by Toide et al (Toide K et al., J. Pharmacol. Exp. Ther. 1995; 274:1370-8), using Z-G-P-AM...				US Patent US10611727 (2020) BindingDB Entry DOI: 10.7270/Q2377CQK
					More data for this Ligand-Target Pair
Prolyl endopeptidase (Homo sapiens (Human))	BDBM298363 ((S)-1-((2S)-1-(4-benzoyloxy-3,5-dimethoxybenzoyl)-...) Show SMILES COc1cc(cc(OC)c1OC(=O)c1ccccc1)C(=O)N1CC(F)(F)C[C@H]1C(=O)N1CCC[C@H]1C#N |r| Show InChI InChI=1S/C26H25F2N3O6/c1-35-20-11-17(12-21(36-2)22(20)37-25(34)16-7-4-3-5-8-16)23(32)31-15-26(27,28)13-19(31)24(33)30-10-6-9-18(30)14-29/h3-5,7-8,11-12,18-19H,6,9-10,13,15H2,1-2H3/t18-,19-/m0/s1	PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	111	n/a	n/a	n/a	n/a	n/a	n/a
UNIVERSITAT DE BARCELONA; FUNDACIO INSTITUT DE RECERCA BIOMEDICA (IRB BARCELONA); IPROTEOS S.L. US Patent					Assay Description POP activity was determined following the method described by Toide et al (Toide K et al., J. Pharmacol. Exp. Ther. 1995; 274:1370-8), using Z-G-P-AM...				US Patent US10125097 (2018) BindingDB Entry DOI: 10.7270/Q22J6DX3
					More data for this Ligand-Target Pair
Cathepsin B (Homo sapiens (Human))	BDBM50463151 (CHEMBL4249696) Show SMILES CCOC(=O)\C=C\C(=O)[C@H](CCc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)N1CCOCC1 |r| Show InChI InChI=1S/C26H37N3O6/c1-4-35-24(31)13-12-23(30)21(11-10-20-8-6-5-7-9-20)27-25(32)22(18-19(2)3)28-26(33)29-14-16-34-17-15-29/h5-9,12-13,19,21-22H,4,10-11,14-18H2,1-3H3,(H,27,32)(H,28,33)/b13-12+/t21-,22-/m0/s1	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	Article PubMed	n/a	n/a	140	n/a	n/a	n/a	n/a	n/a	n/a
Universitat Jaume I Curated by ChEMBL					Assay Description Inhibition of human cathepsin B using Cbz-Phe-Arg-AMC as substrate				Bioorg Med Chem 26: 4624-4634 (2018) Article DOI: 10.1016/j.bmc.2018.07.015 BindingDB Entry DOI: 10.7270/Q29S1TPM
					More data for this Ligand-Target Pair
Cathepsin B (Homo sapiens (Human))	BDBM50463146 (CHEMBL4240920) Show SMILES CCOC(=O)\C=C\C(=O)[C@H](C)NC(=O)[C@H](Cc1ccccc1)NC(=O)OCc1ccccc1 |r| Show InChI InChI=1S/C25H28N2O6/c1-3-32-23(29)15-14-22(28)18(2)26-24(30)21(16-19-10-6-4-7-11-19)27-25(31)33-17-20-12-8-5-9-13-20/h4-15,18,21H,3,16-17H2,1-2H3,(H,26,30)(H,27,31)/b15-14+/t18-,21-/m0/s1	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	Article PubMed	n/a	n/a	140	n/a	n/a	n/a	n/a	n/a	n/a
Universitat Jaume I Curated by ChEMBL					Assay Description Inhibition of human cathepsin B using Cbz-Phe-Arg-AMC as substrate				Bioorg Med Chem 26: 4624-4634 (2018) Article DOI: 10.1016/j.bmc.2018.07.015 BindingDB Entry DOI: 10.7270/Q29S1TPM
					More data for this Ligand-Target Pair
Cysteine protease (Trypanosoma brucei rhodesiense)	BDBM50463151 (CHEMBL4249696) Show SMILES CCOC(=O)\C=C\C(=O)[C@H](CCc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)N1CCOCC1 |r| Show InChI InChI=1S/C26H37N3O6/c1-4-35-24(31)13-12-23(30)21(11-10-20-8-6-5-7-9-20)27-25(32)22(18-19(2)3)28-26(33)29-14-16-34-17-15-29/h5-9,12-13,19,21-22H,4,10-11,14-18H2,1-3H3,(H,27,32)(H,28,33)/b13-12+/t21-,22-/m0/s1	PDB MMDB UniProtKB/TrEMBL B.MOAD GoogleScholar AffyNet	PC cid PC sid UniChem	Article PubMed	n/a	n/a	140	n/a	n/a	n/a	n/a	n/a	n/a
Universitat Jaume I Curated by ChEMBL					Assay Description Inhibition of Trypanosoma brucei rhodesiense rhodesain using Cbz-Phe-Arg-AMC as substrate measured for 30 mins by fluorescence method				Bioorg Med Chem 26: 4624-4634 (2018) Article DOI: 10.1016/j.bmc.2018.07.015 BindingDB Entry DOI: 10.7270/Q29S1TPM
					More data for this Ligand-Target Pair
Cysteine protease (Trypanosoma brucei rhodesiense)	BDBM50463143 (CHEMBL4245127) Show SMILES CCOC(=O)\C=C\C(=O)[C@H](CCc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)OCc1ccccc1 |r| Show InChI InChI=1S/C29H36N2O6/c1-4-36-27(33)18-17-26(32)24(16-15-22-11-7-5-8-12-22)30-28(34)25(19-21(2)3)31-29(35)37-20-23-13-9-6-10-14-23/h5-14,17-18,21,24-25H,4,15-16,19-20H2,1-3H3,(H,30,34)(H,31,35)/b18-17+/t24-,25-/m0/s1	PDB MMDB UniProtKB/TrEMBL B.MOAD GoogleScholar AffyNet	PC cid PC sid UniChem	Article PubMed	n/a	n/a	145	n/a	n/a	n/a	n/a	n/a	n/a
Universitat Jaume I Curated by ChEMBL					Assay Description Inhibition of Trypanosoma brucei rhodesiense rhodesain using Cbz-Phe-Arg-AMC as substrate measured for 30 mins by fluorescence method				Bioorg Med Chem 26: 4624-4634 (2018) Article DOI: 10.1016/j.bmc.2018.07.015 BindingDB Entry DOI: 10.7270/Q29S1TPM
					More data for this Ligand-Target Pair
Cysteine protease (Trypanosoma brucei rhodesiense)	BDBM50463148 (CHEMBL4247707) Show SMILES CCOC(=O)\C=C\C(=O)[C@@H](CCc1ccccc1)NC(=O)[C@H](Cc1ccccc1)NC(=O)N1CCOCC1 |r| Show InChI InChI=1S/C29H35N3O6/c1-2-38-27(34)16-15-26(33)24(14-13-22-9-5-3-6-10-22)30-28(35)25(21-23-11-7-4-8-12-23)31-29(36)32-17-19-37-20-18-32/h3-12,15-16,24-25H,2,13-14,17-21H2,1H3,(H,30,35)(H,31,36)/b16-15+/t24-,25+/m1/s1	PDB MMDB UniProtKB/TrEMBL B.MOAD GoogleScholar AffyNet	PC cid PC sid UniChem	Article PubMed	n/a	n/a	150	n/a	n/a	n/a	n/a	n/a	n/a
Universitat Jaume I Curated by ChEMBL					Assay Description Inhibition of Trypanosoma brucei rhodesiense rhodesain using Cbz-Phe-Arg-AMC as substrate measured for 30 mins by fluorescence method				Bioorg Med Chem 26: 4624-4634 (2018) Article DOI: 10.1016/j.bmc.2018.07.015 BindingDB Entry DOI: 10.7270/Q29S1TPM
					More data for this Ligand-Target Pair
Cysteine protease (Trypanosoma brucei rhodesiense)	BDBM50463152 (CHEMBL4242138) Show SMILES CCOC(=O)\C=C\C(=O)[C@H](CCc1ccccc1)NC(=O)[C@H](Cc1ccccc1)NC(=O)N1CCOCC1 |r| Show InChI InChI=1S/C29H35N3O6/c1-2-38-27(34)16-15-26(33)24(14-13-22-9-5-3-6-10-22)30-28(35)25(21-23-11-7-4-8-12-23)31-29(36)32-17-19-37-20-18-32/h3-12,15-16,24-25H,2,13-14,17-21H2,1H3,(H,30,35)(H,31,36)/b16-15+/t24-,25-/m0/s1	PDB MMDB UniProtKB/TrEMBL B.MOAD GoogleScholar AffyNet	PC cid PC sid UniChem	Article PubMed	n/a	n/a	150	n/a	n/a	n/a	n/a	n/a	n/a
Universitat Jaume I Curated by ChEMBL					Assay Description Inhibition of Trypanosoma brucei rhodesiense rhodesain using Cbz-Phe-Arg-AMC as substrate measured for 30 mins by fluorescence method				Bioorg Med Chem 26: 4624-4634 (2018) Article DOI: 10.1016/j.bmc.2018.07.015 BindingDB Entry DOI: 10.7270/Q29S1TPM
					More data for this Ligand-Target Pair
Prolyl endopeptidase-like (Human)	BDBM298356 ((S)-1-((2S,4S)-1-(4-(benzyloxy)-3,5-dimethoxybenzo...) Show SMILES COc1cc(cc(OC)c1OCc1ccccc1)C(=O)N1C[C@H](C[C@H]1C(=O)N1CCC[C@H]1C#N)SC |r| Show InChI InChI=1S/C27H31N3O5S/c1-33-23-12-19(13-24(34-2)25(23)35-17-18-8-5-4-6-9-18)26(31)30-16-21(36-3)14-22(30)27(32)29-11-7-10-20(29)15-28/h4-6,8-9,12-13,20-22H,7,10-11,14,16-17H2,1-3H3/t20-,21-,22-/m0/s1	PDB UniProtKB/SwissProt GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	176	n/a	n/a	n/a	n/a	n/a	n/a
UNIVERSITAT DE BARCELONA; FUNACIÓ INSTITUT DE RECERCA BIOMÉDICA; IPROTEOS S.L. US Patent					Assay Description POP activity was determined following the method described by Toide et al (Toide K et al., J. Pharmacol. Exp. Ther. 1995; 274:1370-8), using Z-G-P-AM...				US Patent US10611727 (2020) BindingDB Entry DOI: 10.7270/Q2377CQK
					More data for this Ligand-Target Pair
Prolyl endopeptidase-like (Human)	BDBM298359 ((S)-1-((2S,4S)-1-(4-(benzyloxy)-3,5-dimethoxybenzo...) Show SMILES COc1cc(cc(OC)c1OCc1ccccc1)C(=O)N1C[C@H](C[C@H]1C(=O)N1CCC[C@H]1C#N)C(F)(F)F |r| Show InChI InChI=1S/C27H28F3N3O5/c1-36-22-11-18(12-23(37-2)24(22)38-16-17-7-4-3-5-8-17)25(34)33-15-19(27(28,29)30)13-21(33)26(35)32-10-6-9-20(32)14-31/h3-5,7-8,11-12,19-21H,6,9-10,13,15-16H2,1-2H3/t19-,20-,21-/m0/s1	PDB UniProtKB/SwissProt GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	176	n/a	n/a	n/a	n/a	n/a	n/a
UNIVERSITAT DE BARCELONA; FUNACIÓ INSTITUT DE RECERCA BIOMÉDICA; IPROTEOS S.L. US Patent					Assay Description POP activity was determined following the method described by Toide et al (Toide K et al., J. Pharmacol. Exp. Ther. 1995; 274:1370-8), using Z-G-P-AM...				US Patent US10611727 (2020) BindingDB Entry DOI: 10.7270/Q2377CQK
					More data for this Ligand-Target Pair
Prolyl endopeptidase (Homo sapiens (Human))	BDBM298359 ((S)-1-((2S,4S)-1-(4-(benzyloxy)-3,5-dimethoxybenzo...) Show SMILES COc1cc(cc(OC)c1OCc1ccccc1)C(=O)N1C[C@H](C[C@H]1C(=O)N1CCC[C@H]1C#N)C(F)(F)F |r| Show InChI InChI=1S/C27H28F3N3O5/c1-36-22-11-18(12-23(37-2)24(22)38-16-17-7-4-3-5-8-17)25(34)33-15-19(27(28,29)30)13-21(33)26(35)32-10-6-9-20(32)14-31/h3-5,7-8,11-12,19-21H,6,9-10,13,15-16H2,1-2H3/t19-,20-,21-/m0/s1	PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	176	n/a	n/a	n/a	n/a	n/a	n/a
UNIVERSITAT DE BARCELONA; FUNDACIO INSTITUT DE RECERCA BIOMEDICA (IRB BARCELONA); IPROTEOS S.L. US Patent					Assay Description POP activity was determined following the method described by Toide et al (Toide K et al., J. Pharmacol. Exp. Ther. 1995; 274:1370-8), using Z-G-P-AM...				US Patent US10125097 (2018) BindingDB Entry DOI: 10.7270/Q22J6DX3
					More data for this Ligand-Target Pair
Prolyl endopeptidase (Homo sapiens (Human))	BDBM298356 ((S)-1-((2S,4S)-1-(4-(benzyloxy)-3,5-dimethoxybenzo...) Show SMILES COc1cc(cc(OC)c1OCc1ccccc1)C(=O)N1C[C@H](C[C@H]1C(=O)N1CCC[C@H]1C#N)SC |r| Show InChI InChI=1S/C27H31N3O5S/c1-33-23-12-19(13-24(34-2)25(23)35-17-18-8-5-4-6-9-18)26(31)30-16-21(36-3)14-22(30)27(32)29-11-7-10-20(29)15-28/h4-6,8-9,12-13,20-22H,7,10-11,14,16-17H2,1-3H3/t20-,21-,22-/m0/s1	PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	176	n/a	n/a	n/a	n/a	n/a	n/a
UNIVERSITAT DE BARCELONA; FUNDACIO INSTITUT DE RECERCA BIOMEDICA (IRB BARCELONA); IPROTEOS S.L. US Patent					Assay Description POP activity was determined following the method described by Toide et al (Toide K et al., J. Pharmacol. Exp. Ther. 1995; 274:1370-8), using Z-G-P-AM...				US Patent US10125097 (2018) BindingDB Entry DOI: 10.7270/Q22J6DX3
					More data for this Ligand-Target Pair
Procathepsin L (Homo sapiens (Human))	BDBM50463152 (CHEMBL4242138) Show SMILES CCOC(=O)\C=C\C(=O)[C@H](CCc1ccccc1)NC(=O)[C@H](Cc1ccccc1)NC(=O)N1CCOCC1 |r| Show InChI InChI=1S/C29H35N3O6/c1-2-38-27(34)16-15-26(33)24(14-13-22-9-5-3-6-10-22)30-28(35)25(21-23-11-7-4-8-12-23)31-29(36)32-17-19-37-20-18-32/h3-12,15-16,24-25H,2,13-14,17-21H2,1H3,(H,30,35)(H,31,36)/b16-15+/t24-,25-/m0/s1	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	Article PubMed	n/a	n/a	180	n/a	n/a	n/a	n/a	n/a	n/a
Universitat Jaume I Curated by ChEMBL					Assay Description Inhibition of human cathepsin L using Cbz-Phe-Arg-AMC as substrate				Bioorg Med Chem 26: 4624-4634 (2018) Article DOI: 10.1016/j.bmc.2018.07.015 BindingDB Entry DOI: 10.7270/Q29S1TPM
					More data for this Ligand-Target Pair
Cysteine proteinase falcipain 2a (Plasmodium falciparum)	BDBM50463146 (CHEMBL4240920) Show SMILES CCOC(=O)\C=C\C(=O)[C@H](C)NC(=O)[C@H](Cc1ccccc1)NC(=O)OCc1ccccc1 |r| Show InChI InChI=1S/C25H28N2O6/c1-3-32-23(29)15-14-22(28)18(2)26-24(30)21(16-19-10-6-4-7-11-19)27-25(31)33-17-20-12-8-5-9-13-20/h4-15,18,21H,3,16-17H2,1-2H3,(H,26,30)(H,27,31)/b15-14+/t18-,21-/m0/s1	PDB MMDB UniProtKB/TrEMBL B.MOAD GoogleScholar AffyNet	PC cid PC sid UniChem	Article PubMed	n/a	n/a	190	n/a	n/a	n/a	n/a	n/a	n/a
Universitat Jaume I Curated by ChEMBL					Assay Description Inhibition of Plasmodium falciparum falcipain-2 using Cbz-Phe-Arg-AMC as substrate measured for 15 mins by spectrofluorimetric method				Bioorg Med Chem 26: 4624-4634 (2018) Article DOI: 10.1016/j.bmc.2018.07.015 BindingDB Entry DOI: 10.7270/Q29S1TPM
					More data for this Ligand-Target Pair
Cruzipain (Trypanosoma cruzi)	BDBM50463147 (CHEMBL4237990) Show SMILES CCOC(=O)\C=C\C(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)N1CCOCC1 |r| Show InChI InChI=1S/C22H37N3O6/c1-6-31-20(27)8-7-19(26)17(13-15(2)3)23-21(28)18(14-16(4)5)24-22(29)25-9-11-30-12-10-25/h7-8,15-18H,6,9-14H2,1-5H3,(H,23,28)(H,24,29)/b8-7+/t17-,18-/m0/s1	PDB MMDB UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet	PC cid PC sid UniChem	Article PubMed	n/a	n/a	200	n/a	n/a	n/a	n/a	n/a	n/a
Universitat Jaume I Curated by ChEMBL					Assay Description Inhibition of Trypanosoma cruzi cruzain				Bioorg Med Chem 26: 4624-4634 (2018) Article DOI: 10.1016/j.bmc.2018.07.015 BindingDB Entry DOI: 10.7270/Q29S1TPM
					More data for this Ligand-Target Pair

Displayed 1 to 50 (of 102 total )  |  Next  |  Last  >>

Jump to: